• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A型产气荚膜梭菌。十二种抗菌药物的体外和体内活性比较。

Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs.

作者信息

Traub W H

出版信息

Chemotherapy. 1986;32(1):59-67. doi: 10.1159/000238389.

DOI:10.1159/000238389
PMID:2868848
Abstract

Penicillin G and imipenem (N-formimidoyl thienamycin) in vitro were the most active of twelve examined antimicrobial drugs against clinical and fecal isolates of Clostridium perfringens type A. However, vancomycin and fosfomycin, which revealed suboptimal in vitro bactericidal activity, proved as efficacious as penicillin G and imipenem in an experimental mode of murine gas gangrene. Thus, conventional in vitro tests were not uniformly predictive for in vivo (murine) chemotherapeutic efficacy.

摘要

在针对A型产气荚膜梭菌临床和粪便分离株进行检测的12种抗菌药物中,青霉素G和亚胺培南(N-甲酰亚胺硫霉素)在体外表现出最强的活性。然而,体外杀菌活性欠佳的万古霉素和磷霉素,在小鼠气性坏疽实验模型中却证明与青霉素G和亚胺培南一样有效。因此,传统的体外试验并不能一致地预测体内(小鼠)化疗疗效。

相似文献

1
Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs.A型产气荚膜梭菌。十二种抗菌药物的体外和体内活性比较。
Chemotherapy. 1986;32(1):59-67. doi: 10.1159/000238389.
2
Chemotherapy of experimental (murine) Clostridium perfringens type A gas gangrene.实验性(鼠类)A型产气荚膜梭菌气性坏疽的化疗
Chemotherapy. 1988;34(6):472-7. doi: 10.1159/000238611.
3
Susceptibility of 50 isolates of Clostridium perfringens to cefotaxime, fosfomycin, penicillin G and vancomycin; variable tolerance for vancomycin.50株产气荚膜梭菌对头孢噻肟、磷霉素、青霉素G和万古霉素的敏感性;对万古霉素的耐受性存在差异。
Chemotherapy. 1983;29(2):99-103. doi: 10.1159/000238181.
4
Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens.比较克林霉素、利福平、四环素、甲硝唑和青霉素在预防产气荚膜梭菌所致实验性气性坏疽方面的疗效。
J Infect Dis. 1987 Feb;155(2):220-8. doi: 10.1093/infdis/155.2.220.
5
Activity of metronidazole against experimental tetanus and gas gangrene.
J Appl Bacteriol. 1968 Dec;31(4):443-7. doi: 10.1111/j.1365-2672.1968.tb00393.x.
6
Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens.用于预防由产气荚膜梭菌引起的实验性气性坏疽的单一抗菌剂与联合抗菌剂的比较。
Antimicrob Agents Chemother. 1987 Feb;31(2):312-6. doi: 10.1128/AAC.31.2.312.
7
Susceptibility of Clostridium perfringens type A to 23 antimicrobial drugs.A型产气荚膜梭菌对23种抗菌药物的敏感性
Chemotherapy. 1986;32(5):439-45. doi: 10.1159/000238448.
8
Comparative in vitro bactericidal activity of 24 antimicrobial drugs against Clostridium perfringens.24种抗菌药物对产气荚膜梭菌的体外杀菌活性比较
Chemotherapy. 1990;36(2):127-35. doi: 10.1159/000238758.
9
[Effectiveness of cephalosporins in experimental anaerobic gas infection].
Antibiotiki. 1974 Aug;19(8):733-6.
10
The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.与其他广谱头孢菌素、克林霉素和甲硝唑相比,N-甲酰亚胺基硫霉素的体外活性。
Infection. 1983 Jul-Aug;11(4):219-26. doi: 10.1007/BF01641202.

引用本文的文献

1
Metronidazole. A therapeutic review and update.甲硝唑:治疗综述与更新
Drugs. 1997 Nov;54(5):679-708. doi: 10.2165/00003495-199754050-00003.
2
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.亚胺培南/西司他丁。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001.
3
Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens.
用于预防由产气荚膜梭菌引起的实验性气性坏疽的单一抗菌剂与联合抗菌剂的比较。
Antimicrob Agents Chemother. 1987 Feb;31(2):312-6. doi: 10.1128/AAC.31.2.312.
4
Molecular genetics and pathogenesis of Clostridium perfringens.产气荚膜梭菌的分子遗传学与发病机制
Microbiol Rev. 1991 Dec;55(4):621-48. doi: 10.1128/mr.55.4.621-648.1991.